Oslo, January 31, 2025: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces its fourth quarter 2024 results ...
He negotiated with Prime Minister Benjamin Netanyahu in order to receive guarantees that the deal would not prevent Israel ...